precision medicine

The Promise of Precision Medicine

The Promise of Precision Medicine

Posted by  | precision medicine, Research

All cancers are fundamentally disorders of acquired defects in genes. The genes serve as blueprints for all of the components of cells and tissues in the human body. In cancers, faulty blueprints lead to malfunctioning cells that grow uncontrollably, spread throughout the body and overwhelm normal organ functions to threaten life itself. Full realization of(...)

Immunotherapy for Lung Cancer

Immunotherapy for Lung Cancer

Posted by  | precision medicine, treatment

It’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer for certain patients. Learn about the latest advances from our Bloomberg~Kimmel Institute for Cancer Immunotherapy and how we are helping patients with lung cancer live better and longer. Watch the(...)

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

Posted by  | precision medicine

*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed one pharmaceutical company's approach to engineering a cancer patient's own T-cells, the so-called soldiers of the immune system, and injecting them back into patients with astounding success has prompted questions(...)

A Conversation about Cancer

A Conversation about Cancer

Posted by  | precision medicine, Prevention/Screening, Research, Uncategorized

On Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H. Owens Auditorium at the Johns Hopkins Kimmel Cancer Center to honor the philanthropy of Sidney Kimmel for advancing cancer discovery and care. Hundreds more watched via video streaming as Kimmel(...)

Gene Patents Get Supreme Decision

Posted by  | precision medicine

Last week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns Hopkins experts had to say about the topic: "I am thrilled with the Supreme Court's unanimous decision to overturn gene patents.  This was the only choice and will open up(...)